---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-25-000005"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-27T23:53:27.097750+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics stockholders approve reverse stock split (1:25-1:75) and warrant share issuance

## Summary
- At Jan 15 special meeting, stockholders approved issuance of up to 19,762,226 shares upon exercise of Series C/D warrants.
- Proposal 2 approved reverse stock split at ratio between 1-for-25 and 1-for-75, with exact ratio to be set by Board.
- Approvals required for Nasdaq listing compliance and to maintain stock price above minimum bid.
- Votes: Proposal 1 – 7.1M for, 3.3M against, 6.7M abstain, 25.3M broker non-votes.
- Votes: Proposal 2 – 29.0M for, 12.8M against, 0.6M abstain.

## SEC filing metadata
- accession: 0001411690-25-000005
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000005/0001411690-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000005/bngo-20250115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-25-000005
- JSON: https://secwatch.observer/filing/0001411690-25-000005.json
- Plain text: https://secwatch.observer/filing/0001411690-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.